Summary
- Current Price
- As of today, SNDX price is $19.76, down -0.80% on
- Current Price All-Time High
- SNDX price is currently -33.82% below its historical high of $29.86 set on
- Market Cap
- SNDX current market cap is $2B, up +59.06% over the past 365 days
- Revenue
- SNDX current annual revenue is $172.35M, up +627.84% year-over-year
- Next Earnings
- The next earnings release for SNDX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Syndax Pharmaceuticals, Inc. |
| Ticker | NASDAQ: SNDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | syndax.com |
| Employees | 270 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $19.76 | |
| Price, 1D Change | -0.80% | |
| $2B | ||
| - | ||
| - | ||
| 0.63 | ||
| $172.35M | ||
| Revenue, 1Y Change | +627.84% | |
| -$3.29 | ||
| EPS, 1Y Change | +11.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.29 | ||
| EPS Estimate | -$1.60 | N/A |
| EPS Est. Change | +51.39% | N/A |
| $172.35M | ||
| Revenue Estimate | $344.78M | N/A |
| Revenue Est. Change | +100.05% | N/A |
| Current Price | $19.76 | |
| Price Target | $37.00 | - |
| Price Tgt. Change | +87.25% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.80 | -$3.72 | -32.75% | |
| -$3.06 | -$3.29 | -7.60% | |
| -$1.60 | N/A | +51.39% | |
| -$0.36 | N/A | +88.96% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $102.53M | $23.68M | -76.90% | |
| $167.82M | $172.35M | +2.70% | |
| $344.78M | N/A | +100.05% | |
| $503.92M | N/A | +192.38% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $19.76 | |
| $20.45 | ||
| $20.38 | ||
| $19.92 | ||
| $20.80 | ||
| -$0.55 | ||
| 0.63 | ||
| $1.16 | ||
| 42.95 | ||
| 38.33% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $172.35M | ||
| -$3.29 | ||
| $0.00 | ||
| 95.95% | ||
| -$273.08M | ||
| -158.45% | ||
| -$285.42M | ||
| -165.60% | ||
| -$273.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 5.34 | ||
| 4.40 | ||
| 4.12 | ||
| - | ||
| 2 | ||
| -0.46 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 8.12 | ||
| 42.39 | ||
| -7.86 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $64.63M | ||
| $394.07M | ||
| $529.71M | ||
| $528.08M | ||
| $465.08M | ||
| $120.12M | ||
| $345.43M | ||
| $472.00K | ||
| $16.58M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $457.77M | ||
| $438.46M | ||
| $6.98M | ||
| $179.68M | ||
| $6,000.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$322.98M | ||
| $290.04M | ||
| $13.68M | ||
| $187.00K | ||
| -$323.17M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| Barclays | → | |
| Goldman Sachs | → | |
| Mizuho | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Mizuho | → |
Analyst sentiment
Institutional ownership
No data
Screeners with SNDX
FAQ
- What is the ticker symbol for Syndax Pharmaceuticals, Inc.?
- The ticker symbol for Syndax Pharmaceuticals, Inc. is NASDAQ:SNDX
- Does Syndax Pharmaceuticals, Inc. pay dividends?
- No, Syndax Pharmaceuticals, Inc. does not pay dividends
- What sector is Syndax Pharmaceuticals, Inc. in?
- Syndax Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Syndax Pharmaceuticals, Inc. in?
- Syndax Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Syndax Pharmaceuticals, Inc. based in?
- Syndax Pharmaceuticals, Inc. is headquartered in United States
- When did Syndax Pharmaceuticals, Inc. go public?
- Syndax Pharmaceuticals, Inc. initial public offering (IPO) was on March 2, 2016
- Is Syndax Pharmaceuticals, Inc. in the S&P 500?
- No, Syndax Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Syndax Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Syndax Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Syndax Pharmaceuticals, Inc. in the Dow Jones?
- No, Syndax Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Syndax Pharmaceuticals, Inc. last earnings report?
- Syndax Pharmaceuticals, Inc.'s most recent earnings report was on August 4, 2026
- When does Syndax Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Syndax Pharmaceuticals, Inc. is November 2, 2026
Data Sources & References
- SNDX Official Website syndax.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm
- SNDX Profile on Yahoo Finance finance.yahoo.com/quote/SNDX
- SNDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sndx